Bio-techne corp
TECH 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面獲得最高評分，股利評分不錯，值得長期累積部位。若想獲得較好的進場時機，可參考技術面趨勢與波段評分
TECH 近期報酬表現
2.91%
Bio-techne corp
1.19%
同產業平均
0.91%
S&P500
與 TECH 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
A | Agilent technologies, inc. | 5 分 | 3 分 | 2 分 | 3 分 | 3 分 | |
IDXX | Idexx laboratories incorporated | 4 分 | 1 分 | 4 分 | 2 分 | 1 分 | |
WAT | Waters corp | 4 分 | 3 分 | 1 分 | 3 分 | 1 分 | |
BIO | Bio rad laboratories incorporated | 2 分 | 2 分 | 1 分 | 2 分 | 1 分 | |
TMO | Thermo fisher scientific inc. | 4 分 | 4 分 | 5 分 | 3 分 | 3 分 |
- A Agilent technologies, inc.價值 5 分趨勢 3 分波段 2 分籌碼 3 分股利 3 分查看更多
TECH 公司資訊
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.